Company Overview and News

1
CL / Colgate-Palmolive Co. null (Current Report)

2018-09-18 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
CL

47
Top Analyst Upgrades and Downgrades: AMD, Apache, Gold Fields, Marvell, Micron, Oracle, Starbucks, Transocean, United Rentals, Walmart and More

2018-09-18 247wallst - 4
Stocks were indicated to open higher on Tuesday. U.S. equity indexes remain very close to their all-time highs, while most international markets are not close to their highs. One issue that has to be considered is that investors have seen less upside from buying on market pullbacks than in prior years. Investors also need to consider how they want to have their investments positioned for the rest of 2018.
APA GFI.WI AMD WMT ISCA CL BKU MS RIG GFIOF ORCL MRVL FDX AKCA MU URI TRI SBUX GFI ESRX

11
This 4% Yielding Stock Is Undervalued

2018-09-17 seekingalpha
Newell Brands is working through a major turnaround, as the stock has declined nearly 50% in the past year.
NWL PG CL KMB

7
Structural Changes Won’t Change the Narrative for Unilever Stock

2018-09-13 investorplace
Unilever (NYSE:UL, NYSE:UN) appears poised for a new future under a simplified business framework. The provider of household brands such as Lipton tea, Dove soap, and Ben & Jerry’s ice cream wants to redefine its corporate structure. Although this will leave one Unilever stock instead of two, I see no other differences easily visible to shareholders.
GIS UL PG UN CL UNLYF ULVR KHC UNLNF

1
Does Clorox Have Some Cleaning To Do?

2018-09-13 seekingalpha
Everyone knows about Clorox (CLX) and many have even used their products for several decades as well! Whether it’s from cleaning products, cat litter, containers or water filtration, you already crossed Clorox’s path. The company generates sales through their well-known brands on the market. Their 2018 financial year reported a total of $6.1B in sales from which, 80% comes from those well-known brands.
PG CL

47
Dividend Aristocrats Vs. Non-Dividend Aristocrats

2018-08-27 seekingalpha
The Dividend Achievers Index requires at least 10 years of dividend growth, and it applies dividend health screens.
ABT LOW TXN WBA UTX CVS WMT MDT NKE JNJ CL MSFT QCOM MMM

1
Colgate Palmolive (India) Limited - Appointment

2018-08-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
CL CLGQY

1
Colgate-Palmolive's Deceiving Dividend Growth Rate Makes Me Wonder

2018-08-18 seekingalpha
The market has been quite tough with "classic" dividend payers in the consumable goods sector. It seems that between tech and energy, investors find little interest in boring companies like Colgate-Palmolive (NYSE:CL). CL's shares are down double digits (-12% as of August 16, 2018) while the rest of the market is showing another great year. What's wrong with CL? Is it time to buy it on the drop?
CL

1
Skin-care brand Elemis taps Jefferies for sale

2018-08-16 cnbc
British luxury skin-care brand Elemis has tapped investment bank Jefferies Group to explore a sale of the business, sources familiar with the situation tell CNBC.
CL STNR CLGQY JEF

42
PepsiCo And Gilead: 2 Very Different CEO Departures

2018-08-16 seekingalpha
In PepsiCo’s case, Indra Nooyi, CEO for 12 years and with the company for 24 years, has decided to retire. Her successor, an insider, was announced.
NKE JCP GILD PEP CL MSFT FDX UTX INTC MCD DWDP

6
Facebook: Now That The Dust Has Settled...

2018-08-07 seekingalpha
A bet on Facebook is not just a bet on the social network itself but also the company's role in our technological future and its leadership.
FB GOOGL CL CLGQY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CL / Colgate-Palmolive Co. on message board site Silicon Investor.

[email protected] HotStove Club [email protected] HotStove Club [email protected] HotStove Club SPX Cycles SPX Cycles SPX Cycles
Ratu0027s Nest - Chronicles of Collapse Ratu0027s Nest - Chronicles of Collapse Ratu0027s Nest - Chronicles of Collapse Clown-Free Zone... sorry, no clowns allowed Clown-Free Zone... sorry, no clowns allowed Clown-Free Zone... sorry, no clowns allowed
Climate Change Climate Change Climate Change Classic TA Workplace Classic TA Workplace Classic TA Workplace
Cloud, edge and decentralized computing Cloud, edge and decentralized computing Cloud, edge and decentralized computing Drones, Autonomous Vehicles and Flying Cars Drones, Autonomous Vehicles and Flying Cars Drones, Autonomous Vehicles and Flying Cars
Severe weather events, climate change and economics Severe weather events, climate change and economics Severe weather events, climate change and economics Chicago Bears Fan Club Chicago Bears Fan Club Chicago Bears Fan Club
CUSIP: 194162103